Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients
about
Lamarckian evolution explains human brain evolution and psychiatric disordersProteomics Research in SchizophreniaMaking Sense of Blood-Based Proteomics and Metabolomics in Psychiatric ResearchPeripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric researchThe Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Theranostic Biomarkers for SchizophreniaImpaired metabolic reactivity to oxidative stress in early psychosis patientsA three step network based approach (TSNBA) to finding disease molecular signature and key regulators: a case study of IL-1 and TNF-alpha stimulated inflammation.The use of clinical and biological characteristics to predict outcome following First Episode Psychosis.Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis.Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and SchizophreniaSimvastatin augmentation for recent-onset psychotic disorder: A study protocol.The proteome of schizophrenia.Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.Realising stratified psychiatry using multidimensional signatures and trajectories.Blood test for schizophrenia.Systems biology, bioinformatics, and biomarkers in neuropsychiatry.The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients.Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia.Blood-based biomarkers in depression: emerging themes in clinical research.Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.Can proteomics-based diagnostics aid clinical psychiatry?Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia.The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.Lab-on-a-Chip Proteomic Assays for Psychiatric Disorders.Phenotyping Multiple Subsets of Immune Cells In Situ in Formalin-Fixed, Paraffin-Embedded Tissue Sections.Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders.Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders.Identifying Biomarker Candidates in the Blood Plasma or Serum Proteome.The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.Depletion of Highly Abundant Proteins of the Human Blood Plasma: Applications in Proteomics Studies of Psychiatric Disorders.Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients.Maternal Diet, Metabolic State, and Inflammatory Response Exert Unique and Long-Lasting Influences on Offspring Behavior in Non-Human Primates.
P2860
Q21129357-12852B5E-5F0C-43F4-AE35-E65727F3B437Q26766821-F3D368A4-8BD0-41EF-83DA-2BB6FD654F38Q26771434-1B7F1270-2240-4BCA-851A-DF8E071E8558Q27012892-2313F71E-221E-4876-A005-1CDFD05EC3A7Q33451672-04D5F930-BE89-455C-B871-3074E513A61DQ33453744-A2808517-9AC2-46FB-8265-E1BD37F75E6DQ33624412-567E8DCA-6F35-4950-87BA-8085BC3383A2Q34048645-6E0816A6-8CBF-427C-88A2-CF8479C65F25Q35152688-979D8937-8F54-4D29-9426-E502FC2DCEF3Q35457414-9366601C-8831-4023-908D-30A697E09BD1Q35603078-3E278189-2C06-4B0E-9B2E-1655C68CDA7FQ36063627-30752C55-2C26-4B01-8E7F-192E23FCBD5EQ36324327-B9DED5A0-12A7-4A65-8BE0-67F8102247ECQ36848272-EEDD340F-AAEA-4477-86EE-10915AABC021Q36998471-B39BBA73-2E39-4142-B0B5-5A2579C97CA7Q37591548-0632C901-3BBD-4866-8637-A041A966092BQ38038106-FC741DC0-1FE5-474D-A358-4B4A1FA2ABA1Q38069972-4680EEF5-7849-4C0C-B228-E357CD904970Q38170139-FAF389BC-0550-4A6F-BE6F-CA32AB3B5FE3Q38170140-23DD4D4C-32E5-4A37-905B-19B7868FAFF6Q38219783-BDC8B4E0-75EE-4F81-A0EF-4E78F938D145Q38366733-B628ACDF-A328-4984-AAD2-671702240376Q38392369-27FD0B6A-5729-4E8C-A141-FE834D78BF9EQ38672722-4F301411-2021-4BC3-9B0F-DF7BBC45E40FQ38783299-72CBF827-737D-4072-81A6-B9757BD31C6CQ38805367-09298C93-917F-4676-A715-50D099C7A92DQ38939217-A46F9CCD-BBEE-4493-96C9-2AA5CE313F43Q41605632-D651BE5C-31A9-4EE2-B779-3B880D8B3A06Q41611297-975A3D9E-38BC-4F3E-A37C-7E059F36BCB6Q47241901-26A39E09-1AE1-4CA2-BA2C-3CFD69E65041Q47763172-B32DA7FE-978C-4478-A662-AB7EA6DA2D23Q47763181-9EF2B7EC-F98B-4C70-970D-85BD84DE66B9Q47763396-21E4141D-CEA9-4EE4-94A7-B39927C8BBAAQ47787773-C9B6DD84-3835-490A-9980-3EB7E44F2EC9Q48239748-CF1C1F74-818F-45A9-8AEC-087CDC6D921CQ49481418-5AEFEB50-D8CE-4472-92AA-4C90EF11B662Q50578956-B0C5A6F3-1D49-48D5-B8D3-0571FC46A5A1Q51298241-2EAF4AD3-D7FA-46DF-B2E7-12DEA6373ADFQ54942497-032D201C-9910-4990-896C-BCB4CCF4B850Q55024417-24A73968-14C8-46CD-80FD-0CCB290B9C4E
P2860
Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of blood-based ...... apse in schizophrenia patients
@ast
Identification of blood-based ...... apse in schizophrenia patients
@en
type
label
Identification of blood-based ...... apse in schizophrenia patients
@ast
Identification of blood-based ...... apse in schizophrenia patients
@en
prefLabel
Identification of blood-based ...... apse in schizophrenia patients
@ast
Identification of blood-based ...... apse in schizophrenia patients
@en
P2093
P2860
P356
P1476
Identification of blood-based ...... apse in schizophrenia patients
@en
P2093
P2860
P2888
P356
10.1038/TP.2012.3
P577
2012-02-21T00:00:00Z
P5875
P6179
1018680924